Independent Director nominee expected to be elected at Annual Shareholders Meeting in March 2024
CRANFORD, N.J., Jan. 23, 2024 /PRNewswire/ Citius Pharmaceuticals, Inc. , a late-stage.
Citius Pharmaceuticals (CTXR) Appoints Robert J Smith to its Board streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Citius Pharmaceuticals, Inc. ("Citius" or the "Company") , a late-stage biopharmaceutical company dedicated to the development and commercialization of first-in-class critical care products today announced the nomination of seasoned pharmaceutical.
/PRNewswire/ The "Recombinant DNA Technology: Global Strategic Business Report" report has been added to ResearchAndMarkets.com s offering. The global.